Advertisement
Correspondence

Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R

  • Chien-Hung Gow,

    Affiliation: National Taiwan University Hospital, Taipei, Taiwan

    X
  • Jin-Yuan Shih,

    Affiliation: National Taiwan University Hospital, Taipei, Taiwan

    X
  • Yih-Leong Chang,

    Affiliation: National Taiwan University Hospital, Taipei, Taiwan

    X
  • Chong-Jen Yu mail

    jeffery@ha.mc.ntu.edu.tw

    Affiliation: National Taiwan University Hospital, Taipei, Taiwan

    X
  • Published: September 27, 2005
  • DOI: 10.1371/journal.pmed.0020269

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus
Research Article | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020073